Skip to main content
. 2008 May 27;98(11):1753–1758. doi: 10.1038/sj.bjc.6604390

Figure 2.

Figure 2

Serum osteocalcin (A) and bone ALP (B) levels after ZA administration. Data are presented as mean±s.e.; *P<0.05 vs baseline.